Document is current
Any future updates will be listed below
-
Authors
Khateeb, Suhaib
Cavalcante, Ludimila
Alnairat, Noor
Singh, Meghana
Sahin, Ibrahim Halil
Saeed, Azhar
Saeed, Anwaar
- License Information
-
More Information
Article History
Accepted: 5 February 2024
First Online: 19 February 2024
Compliance with Ethical Standards
:
: We report the following conflicts of interest:A.S. (Anwaar Saeed) reports research grants (to institution) from AstraZeneca, Bristol Myers Squibb, Merck, Clovis, Exelixis, Actuate Therapeutics, Incyte Corporation, Daiichi Sankyo, Five Prime Therapeutics, Amgen, Innovent Biologics, Dragonfly Therapeutics, KAHR Medical, and BioNTech and advisory board fees from Merck, AstraZeneca, Bristol Myers Squibb, Exelixis, Taiho, and Pfizer. The remaining authors have no relevant financial interests to disclose.No external funding was received for the conduct of this research or preparation of this manuscript. The authors confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. The authors further confirm that the order of authors listed in the manuscript has been approved by all of us.
: The authors declare no competing interests.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
